Dr. Chauncey W. Crandall, author of Dr. Crandall’s Heart Health Report newsletter, is chief of the Cardiac Transplant Program at the world-renowned Palm Beach Cardiovascular Clinic in Palm Beach Gardens, Fla. He practices interventional, vascular, and transplant cardiology. Dr. Crandall received his post-graduate training at Yale University School of Medicine, where he also completed three years of research in the Cardiovascular Surgery Division. Dr. Crandall regularly lectures nationally and internationally on preventive cardiology, cardiology healthcare of the elderly, healing, interventional cardiology, and heart transplants. Known as the “Christian physician,” Dr. Crandall has been heralded for his values and message of hope to all his heart patients.

Tags: diabetes and aspirin resistance | aspirin against heart attack and stroke | blood-clotting process | anticlotting treatment for people with diabetes | Dr. Chauncey Crandall

Aspirin and Diabetes

Wednesday, 26 September 2012 09:19 AM

According to a new study, patients with Type 2 diabetes may be aspirin resistant, which means that the standard dose given to protect against heart attack and stroke may not work for them.

The study analyzed aspirin’s clotting effects using an analysis of 142 men with Type 2 diabetes, which is the most common form of the disease.

Researchers measured aspirin’s effect on a chemical that is involved in the blood-clotting process, and found that more than half of the participants — 53 percent — were aspirin resistant.

Earlier studies had indicated some degree of aspirin resistance in people with diabetes, but this study suggested that the process may be widespread, said lead author Subhashini Yaturo, M.D., of the Stratton VA Medical Center in Albany, N.Y.

It also demonstrates that “the standard baby aspirin dose (81 mg) may not be adequate for subjects with diabetes for cardiovascular protection.”

More research is needed to identify people with aspirin resistance, so anticlotting drug regimens can be tailored for them, added Dr. Yaturo.

© 2020 NewsmaxHealth. All rights reserved.

1Like our page
Aspirin as an anticlotting treatment may not be as effective for people with diabetes who may be aspirin resistant, a study finds.
diabetes and aspirin resistance,aspirin against heart attack and stroke,blood-clotting process,anticlotting treatment for people with diabetes,Dr. Chauncey Crandall
Wednesday, 26 September 2012 09:19 AM
Newsmax Media, Inc.

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved